Trial Profile

Open-label, Two-period, One Sequence, Multiple Dose, Crossover Study, A Study to Investigate Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal Healthy Male Subjects.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 08 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ertapenem (Primary) ; Valproic acid (Primary)
Indications Bacterial infections; Bipolar disorders; Community-acquired pneumonia; Epilepsy; Intra-abdominal infections; Migraine; Obstetric and gynaecological infections; Skin and soft tissue infections; Urinary tract infections
Focus Pharmacokinetics

30 Nov 2010 Primary endpoints (maximum plasma concentration at steady state, area under the concentration versus time curve) added as reported by ClinicalTrials.gov.
26 Feb 2010 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com